Saturday 17 October 2026
Export GNLN’s income statement to Excel — free account
Greenlane Holdings, Inc.
GNLN Consumer Defensive Tobacco
Greenlane Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.4 million, down 67.2% from fiscal 2024. In the quarter to June 2026, revenue fell 50.4%, EPS grew 76.2% and free cash flow grew 23.8%, each against the same quarter a year earlier.
2.06
0.18
−8.04%
Follow GNLN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 3 | 3 |
+8 more TTM periods Free account |
| (535.74%) | (273.28%) | (231.28%) | (243.86%) | ||
| (381.46%) | (212.20%) | (165.27%) | (96.36%) | ||
ROIC |
(181.44%) | (95.80%) | (96.29%) | (133.33%) | |
Return on Tangible Assets |
(1,367.16%) | (717.06%) | (293.77%) | (281.12%) | |
Average Days of Receivables |
1,002.91 | 534.47 | 131.75 | 324.60 | |
Free Cash Flow per Share |
(8.53) | (8.81) | (26.19) | (77.66) | |
Free Cash Flow |
(34.95) | (36.02) | (24.52) | (13.47) | |
Capital Expenditures |
(19.48) | (18.37) | (8.26) | (0.15) | |
| Other line items | |||||
Cash ROIC |
(110.78%) | (56.81%) | (24.46%) | (105.01%) | |
Accounts Receivable Turnover |
0.50 | 0.58 | 1.49 | 1.44 | |
Accounts Payable Turnover |
2.11 | 2.14 | 2.21 | 1.11 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.75 | |
Average Days of Payables |
141.01 | 119.71 | 117.49 | 178.78 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 274.82 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
1,401.46% | 1,221.33% | 898.87% | 317.67% | |
Share Based Compensation of Revenue |
832.75% | 726.51% | 537.08% | 0.00% | |
Interest Coverage |
1,063.60 | (156.51) | (23.53) | (3.55) | |
Operating CF/Net income |
0.13 | 0.18 | 0.19 | 0.54 | |
Depreciation/Fixed assets |
0.00 | 4.03 | 3.07 | 2.18 | |
Capex/Depreciation |
(44.38) | (37.34) | (10.63) | (0.06) | |
Revenue per Share |
0.72 | 0.82 | 4.65 | 26.83 | |
Operating CF per Share |
(3.77) | (4.32) | (17.36) | (76.82) | |
Capex per Share |
(4.75) | (4.50) | (8.82) | (0.84) | |
Capex to Sales |
6.63 | 5.51 | 1.90 | 0.03 |
Columns are period end dates